Valuation: Medtide Inc.

Market Cap 285.35Cr 330.39Cr 42Cr 37Cr 34Cr 31Cr 59Cr 4.06TCr 60Cr 408.23Cr 160.03Cr 1.99TCr 158.23Cr 154.78Cr 6.85TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 195.54Cr 226.4Cr 29Cr 25Cr 23Cr 22Cr 41Cr 2.78TCr 41Cr 279.74Cr 109.66Cr 1.36TCr 108.43Cr 106.06Cr 4.69TCr EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.02x
Free-Float
28.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.87%
1 week-2.10%
Current month+5.53%
1 month+3.46%
3 months+4.67%
6 months-15.88%
Current year-23.56%
1 week 22.64
Extreme 22.64
25
1 month 20.24
Extreme 20.24
25
Current year 19
Extreme 19
30.46
1 year 19
Extreme 19
41.72
3 years 19
Extreme 19
41.72
5 years 19
Extreme 19
41.72
10 years 19
Extreme 19
41.72
Manager TitleAgeSince
Chief Executive Officer 58 11/06/2020
Director of Finance/CFO 53 01/10/2020
Investor Relations Contact 50 01/09/2023
Director TitleAgeSince
Chairman 58 11/06/2020
Director/Board Member 51 27/01/2022
Director/Board Member 63 27/01/2022
Date Insider Type Main position Quantity % Market Cap.
09/03/26 Other

Chief Executive Officer

6,82,01,112 48.0967%
09/03/26 Other

Director

6,82,01,112 48.0967%
09/03/26 Other

Director

6,82,01,112 48.0967%
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%-2.10%-32.95% - 42Cr
-0.49%-3.58%-0.84%+2.13% 4.92TCr
-2.13%-0.13%+378.16%+584.97% 3.96TCr
+0.22%+2.77%+7.01%+61.95% 3.47TCr
+0.43%-0.97%+29.30%-9.20% 3.44TCr
-1.82%-1.48%+0.52%+32.02% 2.71TCr
+2.16%-4.12% - - 1.62TCr
-1.41%+0.74%+72.92%+116.33% 1.54TCr
+1.17%+3.10%+15.87%+16.79% 1.41TCr
+1.65%+0.28%+19.29%-32.68% 1.3TCr
Average -0.66%-0.61%+54.36%+96.54% 2.44TCr
Weighted average by Cap. -0.74%-0.57%+78.00%+121.16%

Financials

2026 *2027 *
Net sales 68Cr 79Cr 10Cr 8.85Cr 8.18Cr 7.53Cr 14Cr 974.2Cr 14Cr 98Cr 38Cr 476.66Cr 38Cr 37Cr 1.64TCr 88Cr 101.39Cr 13Cr 11Cr 10Cr 9.64Cr 18Cr 1.25TCr 18Cr 125.27Cr 49Cr 610.13Cr 49Cr 47Cr 2.1TCr
Net income - -
Net Debt -90Cr -103.99Cr -13Cr -12Cr -11Cr -9.88Cr -19Cr -1.28TCr -19Cr -128.49Cr -50Cr -625.78Cr -50Cr -49Cr -2.16TCr -108.1Cr -125.17Cr -16Cr -14Cr -13Cr -12Cr -22Cr -1.54TCr -23Cr -154.65Cr -61Cr -753.22Cr -60Cr -59Cr -2.6TCr
Logo Medtide Inc.
Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.
Employees
566
Date Price Change Volume
20/26/20 HK$23.30 +0.87% 1,00,300
17/26/17 HK$23.10 -3.43% 76,600
16/26/16 HK$23.92 -1.97% 1,15,300
15/26/15 HK$24.40 +1.24% 1,08,000
14/26/14 HK$24.10 +0.42% 1,04,900
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
20.12CNY
Average target price
25.19CNY
Spread / Average Target
+25.19%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3880 Stock